In fatty liver disease, hepatic tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β are increased, and these are more increased by the aggravation of NAFLD to more severe stages [10]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.